We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
PUT
Salesforce
CRM
$151B
| $499K | 0.01% |
+8,600
| New | +$465K |
|
677
PUT
Chevron
CVX
$392B
| $496K | 0.01% |
3,800
-26,600
| -88% | -$3.31M |
|
678
PUT
Teekay
TK
$1.01B
| $491K | 0.01% |
7,900
-21,100
| -73% | -$1.22M |
|
679
FormFactor
FORM
$8.28B
| $490K | 0.01% |
+58,983
| New | +$392K |
|
|
ITG
680
DELISTED
Investment Technology Group Inc
ITG
| $489K | 0.01% |
28,999
+2,789
| +11% | +$52.8K |
|
681
Stryker
SYK
$125B
| $481K | 0.01% |
5,700
-608
| -10% | -$49.7K |
|
682
CALL
Ralph Lauren
RL
$22.6B
| $480K | 0.01% |
3,000
-2,600
| -46% | -$401K |
|
683
Norfolk Southern
NSC
$75.4B
| $474K | 0.01% |
+4,600
| New | +$451K |
|
|
GEVA
684
CALL
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $472K | 0.01% |
+4,500
| New | +$383K |
|
|
RPXC
685
DELISTED
RPX Corporation
RPXC
| $470K | 0.01% |
26,452
-21,188
| -44% | -$352K |
|
|
JWN
686
PUT
DELISTED
Nordstrom
JWN
| $469K | 0.01% |
+6,900
| New | +$448K |
|
|
XLRN
687
DELISTED
Acceleron Pharma
XLRN
| $469K | 0.01% |
+13,802
| New | +$462K |
|
688
CALL
General Mills
GIS
$19.1B
| $462K | 0.01% |
8,800
-24,300
| -73% | -$1.3M |
|
|
CAM
689
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $461K | 0.01% |
6,811
-13,501
| -66% | -$870K |
|
690
Adobe
ADBE
$99.5B
| $458K | 0.01% |
+6,330
| New | +$408K |
|
691
PUT
VeriSign
VRSN
$26.2B
| $454K | 0.01% |
9,300
-109,000
| -92% | -$5.43M |
|
|
AREX
692
PUT
DELISTED
Approach Resources Inc.
AREX
| $448K | 0.01% |
19,700
-41,700
| -68% | -$847K |
|
693
Renasant Corp
RNST
$3.98B
| $445K | 0.01% |
+15,313
| New | +$430K |
|
694
RTX Corp
RTX
$290B
| $445K | 0.01% |
+6,122
| New | +$451K |
|
695
CALL
EOG Resources
EOG
$79.2B
| $444K | 0.01% |
+3,800
| New | +$400K |
|
696
3M
MMM
$90.9B
| $441K | 0.01% |
3,682
-126,614
| -97% | -$14.9M |
|
697
Visa
V
$684B
| $439K | 0.01% |
8,336
-193,592
| -96% | -$10.1M |
|
|
EOX
698
DELISTED
EMERALD OIL INC (MT)
EOX
| $439K | 0.01% |
+2,872
| New | +$391K |
|
|
ANDV
699
DELISTED
Andeavor
ANDV
| $436K | 0.01% |
+7,430
| New | +$410K |
|
|
PRXL
700
DELISTED
Parexel International Corp
PRXL
| $436K | 0.01% |
+8,251
| New | +$414K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.